Premaitha Health PLC (LON:NIPT – Get Free Report)’s stock price shot up 2.2% during mid-day trading on Wednesday . The company traded as high as GBX 9.10 ($0.12) and last traded at GBX 9.10 ($0.12). 1,571,557 shares traded hands during mid-day trading, an increase of 17% from the average session volume of 1,348,942 shares. The stock had previously closed at GBX 8.90 ($0.11).
Premaitha Health Stock Up 2.2 %
The firm’s fifty day moving average is GBX 9.10 and its 200-day moving average is GBX 9.10.
Premaitha Health Company Profile
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
See Also
- Five stocks we like better than Premaitha Health
- How to Calculate Options Profits
- The Great CPU Race: AMD and Intel Battle for Dominance
- Financial Services Stocks Investing
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Premaitha Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health and related companies with MarketBeat.com's FREE daily email newsletter.
